| |
|
|
Åse Auli Michelet, Chairman of the Board
Åse Aulie Michelet, M.Sc. in Pharmacy, born 1952, was elected as a Director in Photocure in April 2010. She has previously served on the board of Photocure from 1996 to 2003.
Åse Aulie Michelet has a long and extensive experience from pharmaceutical industry within research, marketing and operations. After nearly 30 years with Nycomed, Amersham and GE Healthcare, her last position with GE Healthcare was as Executive Vice President for global operations in Medical Diagnostics and CEO for GE Healtcare AS. From 2008 to 2010 she was CEO for Marine Harvest ASA. Åse Aulie Michelet has served as a member of the Board of Directors of several public companies. She is a member of the Board of Orkla ASA.
Åse Aulie Michelet holds no shares or share options in Photocure.
|
|
|
Jon Hindar, Director
Jon Hindar, MSc., born 1957, was elected as a Director in Photocure in 2006. He is CEO of NorSun AS. Prior to joining NorSun, Mr. Hindar was Senior Vice President of the Life Sciences Division in Invitrogen. He was president and CEO of Dynal Biotech from 2002 until Invitrogen's acquisition of Dynal in April 2005. Mr. Hindar has 10 years experience in R&D from various positions with Alcatel and BP Chemicals and another 10 years experience in various General Manager roles in the chemical industry. Before joining Dynal, Mr. Hindar was Managing Partner for five years at the Norwegian investment bank; Fondsfinans. Mr. Hindar is an alumni of IMD (Lausanne, Switzerland) where he joined the Executive Development program in 1993/94.
Mr Jon Hindar holds 8,000 shares in Photocure. He holds no share options in the company.
|
|
|
Mats Petterson, Director
Mats Petterson, B.Sc. in Economics and Business Administration, was elected as a Director of Photocure in April 2008.
Mats Pettersson is a board member of H. Lundbeck A/S and deputy chairman of the board of SwedenBio AB. He is member of the board of Ablynx NV.
Mats Pettersson joined Pharmacia in 1976, where he held the position of CFO and different business development positions. Before joining Biovitrum, he was Senior Vice President and member of the Management Committee of Pharmacia Corporation. Mats has been responsible for most of the major transforming mergers in Pharmacia over the last ten years and has spent more than 16 years abroad during his career.
Mats Petterson holds no shares or share options in Photocure.
|
|
|
Eva Steiness, Director
Eva Steiness, MD, D.Sc.(medicine), Professor i Clinical Pharmacology, was elected as a Director in Photocure in April 2008.
Eva Steiness has a long and extensive experience from development and registration of new drugs. She was responsible for R&D and Regulatory Affairs in H. Lundbeck A/S from 1989 to 1998. She revitalized the R&D activities completely and increased focus on the authorities expectations and at the same time marketing’s strategy and needs. The R&D staff increased from 85 to 450 under her leadership, and the productivity and innovation power were very high.
Eva Steiness founded Zealand Pharma A/S in 1998 based on 3 patent applications. She managed the company until 2007, inkluding development of an anti-diabetic compound out-licenced to Sanofi-Aventis.
Eva Steiness holds no shares or share options in Photocure.
|
|
|
Ingrid Wiik, Director
(Born 1945), former President and CEO, Alpharma Inc.
Ingrid Wiik has spent more than 30 years in the pharmaceutical industry, both in R&D and general management, and has extensive leadership and international experience. She was President and CEO of Alpharma Inc. (listed on NYSE), a position she held from January 2000 until June 2006. Prior to this, Ingrid Wiik was Vice President and President of the International Pharmaceuticals Division at Alpharma (1994-1999). She currently holds several Board positions: Algeta ASA, Diagenic ASA, Coloplast AS (Denmark), Human Care (Sweden), Norske Skog ASA and Biotec Pharmacon ASA (Norway); and was previously on the Boards of Statoil ASA and Alpharma Inc.. Ingrid Wiik holds a Master of Pharmacy degree from the University of Oslo, a MSc degree (Biopharmacy) from University of London and a MBA from BI Norwegian Business School.
|
|
|
Xavier Yon, Director
(Born 1940), former President and CEO, Galderma
Xavier Yon has spent more than 40 years in the pharmaceutical industry. He has previously worked for Solvay, Pfizer and Alcon before starting as President and CEO of Galderma in 1989. Under Xavier Yon’s leadership Galderma grew into being the leading dermatology company globally. Since he retired from Galderma in 2004 ha has been Managing Director of XY Consulting. He has broad international experience and has lived in Africa and USA in addition to France.
He is board member of Virbac Aminal Health (France) and Graceway Pharmaceuticals (USA). Xavier Yon holds a degree in Physics, Chemistry and Biology from Sorbonne University, Paris and attended the Advanced Management Program at Harvard University.
|
|
|
| |